1 active not recruiting, 1 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Acute Erythroid Leukemia: new trials by email Literature Review of Acute Erythroid Leukemia trials Research Report on Acute Erythroid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies Aldesleukin, Allogeneic CD56-positive CD3-negative Natural Killer Cells, Allogeneic Hematopoietic Stem Cell Transplantation - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 63 | 2013-06-11 | 2023-11-07 |
| Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia Azacitidine, Laboratory Biomarker Analysis, Pharmacological Study - Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 135 | 2006-11-22 | 2026-08-07 |
Leukemia, Erythroblastic, Acute (2) · Leukemia, Megakaryoblastic, Acute (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Chronic (2) · Myelodysplastic Syndromes (2) · Anemia, Refractory (1) · Anemia, Refractory, with Excess of Blasts (1) · Blast Crisis (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Accelerated Phase (1)
Bone Marrow Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia (2) · Leukemia, Myeloid (2) · Myelodysplastic-Myeloproliferative Diseases (2) · Myeloproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Anemia (1) · Carcinogenesis (1)
Azacitidine (1) · Busulfan (1) · Peripheral Blood Stem Cell Transplantation (1) · Vorinostat (1) · aldesleukin (1) · fludarabine phosphate (1)
M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1)
United States (2)
Lewis R Silverman (1) · Richard E Champlin (1)
N01CM17103 (1), N01CM62204 (1), P30CA013330 (1)